Role of calcitriol and cortisol on human adipocyte proliferation and oxidative and inflammatory stress: A microarray study

Journal of Nutrigenetics and Nutrigenomics

Volumn 1, Issue 1-2, 2007, Pages 30-48

  Sun, Xiaocun ^a   Morris, Kristin L ^b   Zemel, Michael B ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

^b Mead Johnson Nutritionals   (United States)

Author keywords

11 Hydroxysteroid dehydrogenase type 1; Apoptotic gene expression; Calcitriol; Calcitriol cortisone, microarray analysis; Cortisol; Gene expression, patterns; Gene expression, unique regulation; Human adipocyte proliferation

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ADIPONECTIN; CALCITRIOL; CORTISONE; GENE PRODUCT; HYDROCORTISONE; HYPOCALCIN; NOX 4 PROTEIN; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; STANNIOCALCIN 2; TOLL LIKE RECEPTOR 3; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADIPOCYTE; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CALCIUM INTAKE; CELL PROLIFERATION; CONTROLLED STUDY; DATA ANALYSIS; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INFLAMMATION; INTRAABDOMINAL FAT; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NORMAL HUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; SUBCUTANEOUS TISSUE; UPREGULATION;

ADIPOCYTES; ANIMALS; CALCITRIOL; CELL PROLIFERATION; CELLS, CULTURED; GENE EXPRESSION PROFILING; HUMANS; HYDROCORTISONE; MICE; OXIDATION-REDUCTION; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION;

MUS;

EID: 35648992394     PISSN: 16616499     EISSN: 16616758     Source Type: Journal    
DOI: 10.1159/000109873     Document Type: Article

References (37)

1. Livingstone DE, Jones GC, Smith K, et al: Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology 2000;141:560-563.
2. Rebuffe-Scrive M, Krotkiewski M, Elfverson J, et al: Muscle and adipose tissue morphology and metabolism in Cushing's syndrome. J Clin Endocrinol Metab 1988;67:1122-1128.
3. Kotelevstev Y, Holmes MC, Burchell A, et al: 11β-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc Natl Acad Sci USA 1997;94:14924-14929.
4. Masuzaki H, Paterson J, Shinyama H, et al: A transgenic model of visceral obesity and the metabolic syndrome. Science 2001;294:2166-2170.
5. Marin P, Darin N, Amemiya T, et al: Cortisol secretion in relation to body fat distribution in obese premenopausal women. Metabolism 1992;41:882-886.
6. Jamieson PM, Chapman KE, Edwards CRW, et al: 11β-Hydroxysteroid dehydrogenase is an exclusive 11β-reductase in primary cultures of rat hepatocytes: effect of physiochemical and hormonal manipulations. Endocrinology 1995;136:4754-4761.
7. Bujalska IJ, Kumar S, Hewison M, et al: Differentiation of adipose stromal cells: the roles of glucocorticoids and 11β-hydroxysteroid dehydrogenase. Endocrinology 1999;140:3188-3196.
8. Zemel MB: Calcium and dairy modulation of obesity risk. Obes Res 2005;13:192-193.
9. Sun X, Zemel MB: Dietary calcium regulates ROS production in aP2-agouti transgenic mice on high-fat/high-sucrose diets. Int J Obes (Lond) 2006;30:1341-1346.
10. Zemel MB, Richards J, Milstead A, Campbell P: Effects of calcium and dairy on body composition and weight loss in African-American adults. Obes Res 2005;13:1218-1225.
11. 3 modulates human adipocyte metabolism via nongenomic action. FASEB J 2001;15:2751-2753.
12. 2+-dependent mechanism. FASEB J 1998;12:1391-1396.
13. Kim JH, Mynatt RL, Moore JW, Woychik RP, Moustaid N, Zemel MB: The effects of calcium channel blockade on agouti-induced obesity. FASEB J 1996;10:1646-1652.
14. 3 in modulating adipocyte apoptosis. FASEB J 2004;18:1430-1432.
15. 3 inhibits uncoupling protein 2 expression in human adipocytes. FASEB J 2002;16:1808-1810.
16. 3 modulation of adipocyte glucocorticoid function. Obes Res 2005;13:670-677.
17. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, Aach J, Ansorge W, Ball CA, Causton HC, Gaasterland T, Glenisson P, Holstege FC, Kim IF, Markowitz V, Matese JC, Parkinson H, Robinson A, Sarkans U, Schulze-Kremer S, Stewart J, Taylor R, Vilo J, Vingron M: Minimum Information About a Microarray Experiment (MIAME) - toward standards for microarray data. Nat Genet 2001;29:365-371.
18. Zemel MB: The role of dairy foods in weight management. J Am Coll Nutr 2005;24:537S-546S.
19. Sun X, Zemel MB: Calcium and dairy products inhibit weight and fat regain during ad libitum consumption following energy restriction in Ap2-agouti transgenic mice. J Nutr 2004;134:3054-3060.
20. 3 modulation of reactive oxygen species production and cell proliferation in human and murine adipocytes. Obes Res (in press).
21. Thompson WG, Rostad Holdman N, Janzow DJ, Slezak JM, Morris KL, Zemel MB: Effect of energy-reduced diets high in dairy products and fiber on weight loss in obese adults. Obes Res 2005;13:1344-1353.
22. Zemel MB, Shi H, Greer B, Dirienzo D, Zemel PC, Zemel MB, Shi H, Greer B, Dirienzo D, Zemel PC: Regulation of adiposity by dietary calcium. FASEB J 2000;14:1132-1138.
23. Melanson EL, Donahoo WT, Dong F, Ida T, Zemel MB: Effect of low- and high-calcium dairy-based diets on macronutrient oxidation in humans. Obes Res 2005;13:2102-2112.
24. Sharma AM, Chetty VT: Obesity, hypertension and insulin resistance. Acta Diabetol 2005;42(suppl 1):S3-S8.
25. Abate N: Obesity and cardiovascular disease. Pathogenetic role of the metabolic syndrome and therapeutic implications. J Diabetes Complications 2000;14:154-174.
26. Paulmyer-Lacroix O, Boullu S, Oliver C, et al: Expression of the mRNA coding for 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue from obese patients: an in situ hybridization study J Clin Endocrinol Metab 2002;87:2701-2705.
27. Bonnet FP (ed): Fat cell size and number in obese children; in Adipose Tissue in Childhood. Boca Raton, CRC, 1981, pp 133-154.
28. Brook CGD, Lloyd JK, Wolf WO: Relation between age of onset of obesity and size and number of adipose cells. Br Med J 1972;2:25-27.
29. Fantuzzi G: Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005;115:911-919.
30. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I: Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004;114:1752-1761.
31. Weiss R, Caprio S: The metabolic consequences of childhood obesity. Best Pract Res Clin Endocrinol Metab 2005;19:405-419.
32. Pickup JC: Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004;27:813-823.
33. Suganami T, Nishida J, Ogawa Y: A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor α. Arterioscler Thromb Vasc Biol 2005;25:2062-2068.
34. Trayhurn P, Beattie JH: Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory. Proc Nutr Soc 2001;60:329-339.
35. Fruhbeck G: The adipose tissue as a source of vasoactive factors. Curr Med Chem Cardiovasc Hematol Agents 2004;2:197-208.
36. Miner JL: The adipocyte as an endocrine cell. J Anim Sci 2004;82:935-941.
37. Trayhurn P, Wood IS: Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004;92:347-355.